EXCLUSIVE LICENSE AGREEMENT between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and NOCIMED, LLC for SYSTEMS, MATERIALS, AND METHODS TO LOCALIZE AND EVALUATE PAIN AND DEGENERATIVE PROPERTIES OF TISSUE UC Case Nos. SF2005-063, SF2005-064, SF2006-113...Exclusive License Agreement • January 6th, 2022 • Aclarion, Inc. • Services-medical laboratories • California
This license agreement ("Agreement") is made effective this 18th day of January, 2008 ("Effective Date"), by and between The Regents of the University of California ("The Regents"), a California corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200 and acting through its Office of Technology Management, University of California San Francisco, 185 Berry Street, Suite 4603, San Francisco, California 94107, and Nocimed, LLC ("Licensee"), a Delaware limited liability corporation, having a principal place of business at 713 Sandoval Way, Hayward, California 94544.
SUBORDINATED CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENTSubordinated Convertible Promissory Note and Warrant Purchase Agreement • January 6th, 2022 • Aclarion, Inc. • Services-medical laboratories • California
This Subordinated Convertible Promissory Note and Warrant Purchase Agreement (this “ Agreement”) is made as of February 28, 2020 by and between Nocimed, Inc., a Delaware corporation (the “Company”), and each of the purchasers listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
Strategic Collaboration Agreement for Phased Commercialization of the Siemens- compatible NOCISCAN-LS Product of Nocimed, Inc.Strategic Collaboration Agreement • January 6th, 2022 • Aclarion, Inc. • Services-medical laboratories
WHEREAS, Nocimed has CE Marked its NOCISCAN-LS product that is supported by a Clinical Evaluation Report (CER) from a prior clinical study conducted by Nocimed for identifying painful lumbar spinal discs, and for predicting successful discogenic low back pain surgery outcomes.
